Sarepta (SRPT) Analysts Split on Accelerated Eteplirsen Approval - Barron's
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq touch new peaks as Treasury yields cool, oil slips
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.45 -0.04 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.49 | 52 Week High | $63.73 | |||
| Open | $17.60 | 52 Week Low | $8.00 | |||
| Day High | $17.65 | P/E | N/A | |||
| Day Low | $17.09 | EPS | $-5.69 | |||
| Volume | 612,533 | |||||
